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G R A P H I C A L A B S T R A C T
A B S T R A C T
Many causes of heart muscle diseases and skeletal muscle diseases are inherited and caused by mutations in
genes of sarcomere proteins which play either a structural or contractile role in the muscle cell. Tissue samples
from human hearts with mutations can be obtained but often samples are only a few milligrams and it is
necessary to freeze them for storage and transportation. Myoﬁbrils are the fundamental contractile components
of the muscle cell and retain all structural elements and contractile proteins performing in contractile event;
moreover viable myoﬁbrils can be obtained from frozen tissue.
 We are describing a versatile technique for measuring the contractility and its Ca2+ regulation in single
myoﬁbrils. The control of myoﬁbril length, incubation medium and data acquisition is carried out using a
digital acquisition board via computer software. Using computer control it is possible not only to measure
contractile and mechanical parameters but also simulate complex protocols such as a cardiac cycle to vary
length and medium independently.
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Method details
Many experimental systems have been used for the study ofmuscle contraction. Singlemolecule or
single ﬁlament type assays allow unlimited control over incubatingmedium and protein composition
but do not have the structural organization of a muscle. Chemically skinned muscle cells or ﬁbers
allow for the measurement of contractility but response to changes in the medium is limited by
diffusion and results may be confused by non-sarcomeric elastic elements. The optimum preparation
for studying contractility is the myoﬁbril – the fundamental unit of striated muscle. Myoﬁbrils are
1mm in diameter and up to several 100mm long. Myoﬁbrils are built up from repeating contractile
subunits called sarcomeres, composed of actin andmyosin ﬁlaments arranged in parallel. Powered by
energy of ATP, myosin heads push actin ﬁlaments alongside causing actin and myosin ﬁlaments to
slide past each other. Such process results in shortening of sarcomeres, myoﬁbrils and the whole
muscle cell. The troponin complex together with tropomyosin, which sterically blocks interaction of
myosin with actin at low Ca2+ concentration, controls this process [1]. Not much is yet known about
the modulation of this process by other sarcomeric proteins, such as myosin binding protein C, titin,
nebulin and obscurin. But there is no doubt that this is of physiological importance [2–6]. It was found
that the most causes of heart diseases and muscular dystrophies are inherited and caused by
mutations in genes of sarcomere proteins [7,8]. What is more, changes in isoform protein expression,
phosphorylation [9] and oxidation [10] also affect myoﬁbril contractility in several ways. The muscle
diseases not only diminish the quality of life but also are one of the highest causes of death.
Comprehensive experimental studies of the mechanisms leading to the diseases are important as for
the choice of treatment as well as for the discovery of new ones [11,12].
Myoﬁbrils can be isolated in sufﬁcient quantities fromonly a fewmilligrams of fresh or frozen tissue
samples or cells meaning that the sources are potentially unlimited. The preparation preserves native
organization of sarcomeric and structural proteins. The use ofmyoﬁbrils in contractile experiments has
many practical advantages compared to the use of permeabilised muscle ﬁbers. Because of myoﬁbrils
smaller diameter there are nodiffusional limitations (<1ms) and rapid solution changes are easy so that
the quick processes of contraction and relaxation canbe studied. Dynamics of individual sarcomeres can
be followed. However, the small size of myoﬁbrils requires special apparatus.
The early apparatus design to measure force in single myoﬁbrils can be dated back to the papers of
Iwazumi [13] and Cecchi et al. [14,15] that also provide the most detailed description of the system.
Another successful apparatus setup to study single myoﬁbril contractility and elasticity is based on a
modiﬁed atomic force microscope [16,17]. The later setup did not demonstrate any practical
advantages over the original one in terms of system throughput and signal-to-noise ratio. In both cases
the principle of the measurement of force in single myoﬁbrils is based on the use of a L-shaped
cantilever as a force-sensing element. In the ﬁrst case the cantilever acts as an obstacle creating a
shadow on a photodiode sensor, in the second case the cantilever reﬂects a laser beam onto a
photodiode sensor. In both cases the changes in total proportion of light on the two halves of a split
 This single myoﬁbril force assay is well suited for physiological measurements. The system can be adapted to
measure tension amplitude, rates of contraction and relaxation, Ca2+ dependence of these parameters in dose-
response measurements, length-dependent activation, stretch response, myoﬁbril elasticity and response to
simulated cardiac cycle length changes. Our approach provides an all-round quantitative way to measure
myoﬁbrils performance and to observe the effect of mutations or posttranslational modiﬁcations. The
technique has been demonstrated by the study of contraction in heart with hypertrophic or dilated
cardiomyopathy mutations in sarcomere proteins.
 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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photodiode are used to calculate the deﬂection of cantilever. As the typical response time of small
photodiodes is less than 10ns, such a force transducer can be used to study very fast dynamic
processes. This approach has demonstrated its high efﬁciency in studies of myoﬁbril contractility
[9,18–20]. However thismethod is still not widely used. One of the reasons is that detailedmechanical
designs of the apparatus andmany techniques andmethodological aspects have not been described in
sufﬁcient detail. Moreover, to our best knowledge, software for apparatus control and data analysis,
which would facilitate further development in this area of research, has not been described.
Here we describe our setup for single myoﬁbril measurements, providing the experimental
methodology and describing the software for data acquisition and analysis. The basic system is further
enhanced by adding controllability of muscle length, multi-solution changer, real-time analysis of
sarcomere length, and software support. The apparatus can be used as a versatile instrument for
studyingmuscle contractility andmechanics. By changing the compliance of cantilever tip it is easy for
adapting the system to larger systems such as single cardiac cell studies.
In this paper, we also demonstrate the potential of this by presenting a novel approach to the study
of contractility in cardiac myoﬁbrils. As we know, measurements of myoﬁbril contraction are
routinely done in an isometric regime. In contrast, natural contraction and relaxation are naturally
accompanied with the changes in muscle length. This is particularly important in studies of
contractility of heart where the contraction-relaxation cycle is coupled with the heart volume
changes. This is an important factor because cardiac preload (stretching in diastole) increases the
cardiac response in systole – the Frank-Starling mechanism. We can simulate the cardiac cycle by
coupling the timing of changes in Ca2+ concentration with the myoﬁbril stretch and release.
Materials and methods
Human cardiac tissue samples
Human heart samples were donor hearts samples, for which no suitable recipient was found, from
St. Vincent’s Hospital, Sydney, Australia. Donor hearts had no history of cardiac disease and normal
ECG and ventricular function and were obtained when no suitable transplant recipient was found.
Ethical approvalwas granted by the Research Integrity, Human Research Ethics Committee, University
of Sydney (Protocol No 15401) for collection and distribution of the human heart samples and by
the NHS National Research Ethics Service, South West London REC3 (10/H0803/147) for study of the
samples. Written consent was obtained with PIS approved by the relevant ethical committee. The
investigation conformed to the principles outlined in the Declaration of Helsinki.
Mouse cardiac tissue samples
Experiments and animal handling were done in accordance with the guidelines of the Imperial
College London. Mice were killed by cervical dislocation as required by Schedule I of the UK Animals
(Scientiﬁc Procedures) Act 1986. The left ventricle was dissected and snap frozen before storage in
liquid nitrogen. In accordance with the United Kingdom Animal (Scientiﬁc Procedures) Act of 1986,
this study did not require a Home Ofﬁce project license because no regulated procedures were carried
out.
Preparation of myoﬁbrils
To prepare myoﬁbrils we used a method described earlier [9,21]. 1–3 small pieces of muscle
samples (totalweight of 2–5mg, but can be as small as 1mg), frozen in liquid nitrogen,were immersed
and quickly mixed-up in a 2ml eppendorf LoBind tube ﬁlled with ice-cold permeabilisation solution.
The permeabilisation solution contained (mM): Tris 10 (pH 7.1), NaCl 132, KCl 5, MgCl2 1, EGTA 5,
dithiothreitol (DTT) 5, NaN3 10, 2,3-butanedione-monoxime (BDM) 20, and 1% peroxide- and
carbonyl-free Triton X-100. BDM in the preparation solution prevented the prepared myoﬁbrils from
shortening and increased storage time. The following protease inhibitors (mM) were also added:
chymostatin 10, pepstatin 5, leupeptin 10 or 40 (40mM were added if myoﬁbrils were used for
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mechanical studies), E-64 (trans-Epoxysuccinyl-L-leucylamido(4-guanidino)butane) 10, and PMSF
(phenylmethlysufonylﬂuoride) 200. The tubecontaining the samplewasplacedona shakerunder slight
agitation on ice for 3h. After permeabilization the solution was removed by pipette and the
permeabilised samplewas washed by incubation inwashing solution (as permeabilisation solution but
without Triton X-100 and BDM) for 15min and then the samplewas homogenized for 15swith a Ultra-
Turrax disperser T8 at speed setting 5 (S8N-5G dispersing tool, IKA Werke GmbH & Co., Staufen,
Germany) toproducea suspensionofmyoﬁbrils. The suspensionwas lefton ice for5minto letmyoﬁbrils
to settle down. Then the myoﬁbrils were pelleted by low speed centrifugation. We used a MSE Micro
Centaur centrifuge (Sanyo,UK) at low speed for 1–2min. A supernatantwas pipetted out leaving a pellet
containingmyoﬁbrils. About 300mL of freshwashing solutionwas added to the tube and the pellet was
re-suspended by pipetting in and out and kept on ice for use in experiments for up to 5 days.
Instrumentation overview
Our apparatus for singlemyoﬁbril studies was constructed around an invertedmicroscope (Eclipse
Ti-U, Nikon UK Ltd., Surrey, UK). A CCD camera (Rolera XR, Qimaging, Surrey, Canada) was connected
to the left port of themicroscope. Twomicromanipulators (MP-285, Sutter Instruments, Novato) were
mounted on the left and on the right side of the microscope using either custom-made or MT-71-12
(Sutter Instruments) micromanipulator stand. In some experiments a manual micromanipulator
(Huxley type) was used instead of the motorized. The complete setup was positioned on an anti-
vibration table (63-564, TMC).
Experimental procedure
A small volume (10–30mL) of myoﬁbril solution was pipetted onto a coverslip of a custom made
temperature-controlled bath chamber, which was positioned on the microscope stage. The bath
chamber was made of anodized aluminum with water circulation ﬂow channels for additional
temperature control using a thermostatic water bath circulator. The bath chamber had a round hole in
the center thatwas closed by a coverslip. Aftermyoﬁbrils were added, the bath chamberwas ﬁlledwith
relaxing solution supplemented with the above mentioned protease inhibitors. Most of the myoﬁbrils
slightly adhered to the coverslip. Using two specially prepared ﬁne glassmicrotools, eachmounted onto
a micromanipulator, a selected myoﬁbril or small bundle were picked up and positioned horizontally.
The solution in the bath chamber was kept at about the same level during experiments using a
peristaltic pump (Instech P720, Harvard Apparatus, USA) in suction mode. The experiments were
performed in a temperature-controlled room at 178C.
Experimental solutions
Relaxing (0.01mM Ca2+) and activating (3.16–0.1mM Ca2+) solutions contained (mM): MOPS 10
(pH 7.0), MgATP 5, free Mg2+ 1, DTT 5, phosphocreatine 10, and creatine kinase (200U/mL), bacterial
purine nucleoside phosphorylase (200U/mL), 7-methylguanosine 0.3. The Ca-EGTA:EGTA ratio was
set to obtain 10mM total EGTA and the desired free [Ca2+]. Potassium propionate and sodium sulphate
were added to adjust the ionic strength of the ﬁnal solution to 200mM. Passive stiffnesswasmeasured
in Ca2+-free relaxing solution containing also 30mM BDM.
Preparation of microtools
Both glass microtools were prepared from capillary glass tubing (borosilicate glass, 1mm in
diameter) using a pipette puller (PC-10, Narishige) and microforge (MF-900, Narishige). To prepare the
L-shaped cantilever force probe, the glass tubingwas pulled to obtain a pipettewith a tip at least 1.5mm
longandwithanearly constantdiameterof10–12mm.Theextramaterialwas cutoff and theopenendof
the pipette was closed by heating. The pipette was bent by heating to a right angle at 1.2–1.5mm from
the tip, forming a strain sensitive cantilever. This glass tool actedas a force sensor. Another, straight glass
microtool also had a tip of about 10mmbut the taper was short. Thismicrotool wasmuch stiffer and its
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function was to control the position of the other end of the myoﬁbril. This stiff microtool was mounted
onto a piezo actuator from the left side and was used to change myoﬁbril length.
To increase the contrast of the projected image on the photodiodes, the region from the tip to the
bend was blackened using the microforge. We used the following technique for that: the cantilever
part was positioned vertically, at some distance from the heating wire (about 70–90mm) and then
high heat was turned on; the cantilever was quickly progressively blackened during several seconds
likely due to the platinum oxide deposition from the heater wire onto the relatively cold glass surface.
Manipulation of myoﬁbrils with a pair of microtools
Each micromanipulator held a specially prepared microtool, which was used for holding and
positioning the myoﬁbrils. The right micro-tool also acted as cantilever force sensor. The left micro-
tool was attached to a piezo actuator to change the length of the mounted myoﬁbril.
The technique formyoﬁbril attachment is shown in the Supplementary Video (Video 1). Firstly, the
left glass microtool was positioned above a myoﬁbril. A slight touch of one myoﬁbril end by the tip of
the left straight microtool was sufﬁcient for ﬁrm attachment of the myoﬁbril to the tool. Then the
attached myoﬁbril end was lifted up using the micromanipulator whereas the opposite end of the
myoﬁbril stayed attached to the coverslip. Holding one end of the myoﬁbril above the cover slip
surface, the cantilever tip (right-sided micromanipulator) is brought under the myoﬁbril. A gentle
swiping motion of the cantilever tip on the myoﬁbril surface causes the myoﬁbril end to attach to
the cantilever tip. The myoﬁbril is then slightly stretched and lifted off the cover slip. The free end of
the myoﬁbril wraps around the cantilever tip. Such wrapping increases the area of contact and
improves attachment between cantilever tip and myoﬁbril. At the same time, the position of left
microtool is continuously adjusted to avoid overstretching of themyoﬁbril. Finally, the position of the
two glass microtools is adjusted to ensure that the myoﬁbril is suspended in a horizontal plane.
Force transducer
The beam of a 5mWHeNe laser (Lasos, LGK 7628) was directed via the microscope condenser onto
a force probe cantilever by means of two adjustable mirrors, The image of the cantilever tip was
projected via the microscope optical system (40 objective and 1.5 intermediate magniﬁcation)
between the two light sensitive areas of double photodiode (Spot-2D, UDT Sensors, Hawthorne, CA).
The laser beam illuminated the photodiode cells and generated a current that was proportional to
the intensity of the light illuminating the corresponding photodiode cell. The current output of the
photodiodeswas dependent on the displacement of the cantilever. The current difference between the
two photodiodes was proportional to the deﬂection of the force probe.
The signal inputs from each photodiode cell were differentially ampliﬁed, then subtracted and the
signal differencewas recorded. For this purposewe used a dual operational ampliﬁer (OP270FZ)with a
pairs of gain resistors (200kV, RC55Y) as current-to-voltage ampliﬁers. A differential operational
ampliﬁer AD624CDZ was used to ﬁnd the difference of signals. The circuit was fed with a precision
power supply. For power supply decoupling, 6.8mF tantalum capacitors were soldered between the
each power supply terminal and the ground. In addition, 0.1mF ceramic capacitors were placed close
to the power supply terminals of every operational ampliﬁer. The circuit with bi-cell photodiode and
signal ampliﬁer was mounted onto a XY translation stage with through-hole (made of NT33-488,
Edmund Optics). The XY translation stage was connected to the right side microscope port with a
40cm length tube. The total resulting magniﬁcation of cantilever on photodiodes was 121.4. The
translation stages were used to adjust the position of the photodiode so the projection of cantilever
was right between the two split photodiode elements. For easy positioning, the shadows of the
cantilever tip and photodiode were both projected onto a white surface screen behind.
Measurement of cantilever force probe compliance
The compliance of each cantilever force probe was measured by comparing it against a calibrated
micro-force generator (see below). The micro-force generator pushed the end of the cantilever with
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different forces and the ratio of tip deﬂection to force was calculated. The prepared cantilever force
probe had the compliance of 2–17mm/mNwhen deﬂected by small forces pulling perpendicularly. The
deﬂection of the cantilever tip is proportional to the force acting on the end of the tip and is detected
with the optical system.
Micro-force generator to measure cantilever compliance
A moving coil meter is used as the force-generating element of a micro-force generator [15]. The
torque produced by the coil in the magnetic ﬁeld is proportional to the current within the range of
rotation of the pointer. For our setup we used a conventional ammeter (Sifam, RS-components,
1968418). The ammeter was powered by a regulated DC power supply (Thurlby Thandar, PL320). A
resistor (474MV) in serieswasadded todecrease the current. Thecurrentﬂow in thecoil dependson the
resistor and isproportional to the appliedvoltage. Tocalibrate the ammeter responseweused itﬁrstlyas
a balance scale, equilibrating the magnetic force with the gravitational force (known weight). For this
purpose, the ammeter was placed in upright position with the pointer aimed upwards. A series of small
pieces of thin copperwire of knownweights (range0.1–2mg)were suspendedon thepointer tip and the
applied voltage (current) was increased until the pointer returns to its original neutral position on the
scale. The force generatedby the pointer (inmN)was plotted against the applied voltages. A straight line
was ﬁtted to the data and the slope was determined. Such a calibrated ammeter, with known output
force per voltage (1.2900.03mN/V, R2=0.9999) was used as a micro-force generator.
Calibration of force transducer
To calibrate the photodiode response, the double photodiode sensor was moved using the
micrometerof thevertical translation stageonwhich itwasmounted instepsacross theprojectionof the
cantilever force probe. The photodiode output signal was measured to ﬁnd the voltage–displacement
conversion factor (usually0.8mm/V). Thedifferential responseofphotodiodes to cantilevermovement
was recorded before each experiment. An alternative method for calibrating photodiode response is to
directly move the cantilever force probe by synchronous movement of the two micromanipulators.
Ultrafast two solutions change system
Myoﬁbrils were activated and relaxed by step changes in Ca2+ concentration achieved bymoving a
double-barrelled micropipette across the mounted myoﬁbril. The pipette was pulled from Q glass
capillary (TGC200-15, Clark Electromedical Instruments), incised and broken along the line using a
diamond glass cutter, and, if required, polished by hand with a ﬁne polishing stone. The ﬁnal outer
diameter of the preparedQ pipette was 300–500mm. The pipette was clamped on a holder mounted
onto the spline shaft of a steppermotor (Z26544-05, Haydon Kerk)with a linear travel of 0.102mmper
step and with the velocity of almost 5ms per step. The systemwas mounted onto a 3-axis positioning
stage (combined fromM-433 translation stages, Newport). Tubing was inserted into each septum and
glued. The other ends of the tubing were connected to syringes ﬁlled with activating and relaxing
solutions. Solution ﬂowwas driven by gravity and the ﬂow rate was controlled by the height between
the reservoirs and the experimental chamber (with the ﬂow rate about 0.3ml/s). Themicropipettewas
positioned perpendicular to the long axis of the myoﬁbril. Both channels of the double pipette were
continuously perfusedwith relaxing and activating solution during experiments. At the initial position
of the pipette, a ﬂow of relaxing solution running from one pipette barrel was aimed directly onto the
myoﬁbril. To quickly change solutions, the motor moved the pipette horizontally (by 0.2mm)
switching the solution streams directed toward themountedmyoﬁbril. The time for solution switch to
complete was less than 10ms.
Multiple solution change system
As one barrel ofQ pipette was constantly perfused with relaxing solution, the second barrel could
be perfused with any one of 8 solutions. An 8-channel valve (HVXM 8-5, Hamilton, VWR, Lutterworth,
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UK) regulated which activation solution was supplied. The valve has 8 inlets but only one outlet. A
stepper motor (21NRLH-LNN-NS-00, National Instruments, UK), controlled via a stepper drive
(P70530, National Instruments, UK), changed the position of the valve plug.
Myoﬁbril length actuator
Themyoﬁbril lengthwas altered via the left glass microtoolmounted onto a piezo-actuator using a
B-8B ball joint adapter (without attachment bar) and UPN-C pipette holder (Narishige). The piezo
actuator (P-212.4S, Physik Instrumente; controlled by E-471.20 ampliﬁer) was equippedwith a servo-
control module E-509.S1 for closed-loop operations. The function of such length actuators was
automatic myoﬁbril length regulation in fast and low speed operations such as fast and slow release-
restretch, sinusoidal perturbations and cardiac cycle simulations.
The protocol for release-restretch was the following. When a myoﬁbril was activated with high
[Ca2+] and the force reached a plateau, a fast piezo-electric expansion (20% of the myoﬁbril length in
2ms) brings the myoﬁbril to the slack state. After a short hold period of 20ms, the piezo-electric
element contracted (in 2ms) bringing the myoﬁbril back to its original length.
Data acquisition and apparatus control
Apparatus control and data recording were done using a data acquisition device (NI USB-6251,
National Instruments, Newbury, UK) and custom-written software in the LabVIEW 2015 environ-
ment (National Instruments, Newbury, UK). The following signalswere acquired, and then visualized
and recorded: the signal from the force transducer; the actual piezo actuator position; each step
command sent to the steppermotor controller of the fast solution change system; and each change in
the valve position of the multi-solution change system, where the number of spikes/peaks encoded
the valve position. The sampling rate was 1kHz. The peak-to-peak background noise in the signal
from force transducer was 50–300mV at low frequencies (0.2–10Hz) and 5–30mV at higher
frequencies
Sarcomere length measurement
Sarcomere length was monitored in real time using the Fast Fourier Transform of the myoﬁbril
image. A region of interests was drawn around the mounted myoﬁbril and its image proﬁle was
extracted. The power spectrumof the proﬁlewas calculated. The spatial frequencies outside those that
were related to the experimental sarcomere length (1–4mm) were cut-off. The myoﬁbril length was
adjusted manually by a micromanipulator to set the mean sarcomere length to the desired value.
Data analysis
In the data analysis of contraction/relaxation experiments, previously saved experimental datawas
loaded. Based on the acquired metadata, the program automatically identiﬁed the following
parameters: Ca2+ transients; activating [Ca2+] based on the valve position characterizing the
concentration of Ca2+ in activating solution. All contraction-relaxation cycles were numbered and
their activation and relaxation phases were automatically and accurately separated. After calibration
parameters were applied, the trace segments were ﬁtted with single exponential or linear ﬁt with
instant visual feedback. The edge between the slow relaxation phase and the fast relaxation phase and
the segment of the slow phase to be ﬁtted with linear was selected manually using cursors. The
maximal tension was calculated from the difference between the baseline and the exponential
plateau.
The rate constants for the exponential force development upon activation (kACT) and fast phase of
relaxation (kREL) were evaluated by curve-ﬁtting using Levenberg–Marquardt nonlinear least square
algorithm in LabVIEW.
y ¼ ymax þ ðy0yplateauÞexpðktÞ
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The slow phase can be ﬁt with a linear ﬁt and characterized by the rate constant kLIN calculated
from the slope of the linear ﬁt by normalizing it to the maximum tension.
kLIN ¼ slopeymax
The maximum tension response to different [Ca2+] was ﬁt with the Hill equation and [Ca2+] for the
development of half maximal force response (EC50) and nH can be estimated from this ﬁtting.
F ¼ Fmax ½Ca
2þnH
EC50þ ½Ca2þnH
Data were ﬁtted with the Hill equation in GraphPad Prism 6 (GraphPad Software, San Diego, CA).




The measurement principle of the apparatus has already been described earlier and our apparatus
is a development of a previous instrument [22].We show here important improvements in the control
of muscle length, of experimental solution changing, in real-time analysis of sarcomere length, and in
control software. The main components of the mechanical and optical setup are shown in Fig. 1a–f.[(Fig._1)TD$FIG]
Fig. 1. Experimental setup. (a, b) Schematic overview (a) and photograph (b) show the key elements of the apparatus. (c, d)
Schematics (c) and photograph (d) of multi-solution change system. (e) Schematics of cantilever and ultrafast solution change
system. The left-sided microtool is relatively stiff and is mounted onto a piezo actuator for fast myoﬁbril length change. The
right-sided glass microtools is a high compliance L-shaped cantilever that acts as a force sensor. The inset shows a photograph
showing the shape of the cantilever tip. (f) The photograph shows twomicrotools holding a smallmyoﬁbril bundle. The relaxing
and activating solutions are applied via the adjacent barrels of a double-barreled (Q) micropipette. The numbers on the ﬁgure
indicate: 1 – inverted microscope; 2 – camera; 3 – laser; 4 and 5 –mirrors; 6 – microscope condenser; 7 – bathmounted onto a
microscope stage; 8 – XY positioning stage; 9 – segmented photodiode; 10 – projection plane for visual control of cantilever
positioning; 11 – left microtool; 12 – right microtool (cantilever force sensor); 13 – piezo actuator; 14 and 15 – left and right
micromanipulators for the positioning of left and right microtool, respectively; 16 – double-barreled Q pipette; 17 – stepper
motor controlling the position of the double-barreled Q pipette; 18 – XYZ positioning stage for the ultrafast two solutions
switching system; 19 – stepper motor controlling the valve opening of the eight-channel valve; 20 – eight-channel valve.
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The apparatus consists of an inverted microscope, a camera to capture images and two
micromanipulators for manipulating and positioning myoﬁbrils by means of two microtools. One
of themicrotools acts also as a force-sensing cantilever. A laser beam is directed onto the cantilever tip.
Under laser illumination, the image of the cantilever is projected through the optical path of the
microscope onto a photodiode position detector. The response of the photodiode based force
transducer is linearly dependent on the cantilever deﬂection produced by the myoﬁbrillar force
applied to it.
The myoﬁbril state is switched from contraction to relaxation and back by rapidly moving the
solution ﬂow bathing the myoﬁbril from one of two solution streams running from the double-
barreled Q pipette to the other. A motor controls the position of an 8-channel valve that regulates
which one of eight activating solutions is being delivered. Tubings connect syringes with different
activating solutions to the valve inlets. The valve output is fed to one side of the double-barreled Q
pipette. The other side of the pipette is fed with relaxing solution. Solution ﬂow is driven by gravity
from the elevated syringes. The motorized valve system to supply multiple solutions is more reliable
and with less solution mixing alternative to the systems based on solenoid valves with a multi-
barrelled manifold.
Apparatus control and acquisition software
The performance of the apparatus critically depends on the ability to control various actuators at
speciﬁed times with millisecond accuracy. The LabVIEW programming development environment
was used for this purpose. Fig. 2 shows the schematics of apparatus control principle and data
acquisition via a data acquisition (DAQ) device.
The software allows the automatic measurement of myoﬁbril length and of the mean sarcomere
length in real-time; it automates the solution change system (valve selection and position of the Q
pipette); it generates an arbitrarywaveform to control the position of the length actuator and controls
the timing of the fast solution change system.
The camera view is used to set up the apparatus and tomount themyoﬁbrils. The sarcomere length
is calculated in real time from the Fast Fourier Transform of the myoﬁbril image. Supplementary Fig.
S1 shows the graphical interface used for sarcomere length analysis. The graphical interface of the
control software is shown in Fig. 3. Using the panels for construction of the length change and
solution-change protocols, it is possible to apply any combination of length and solution changes and
to generate sequences of control commands to automate tasks. The displacement of the length
actuator can be easily scaled to adapt to various lengths of myoﬁbril samples. Experiments are viewed
in real time and data are saved for analysis. The signals from the force transducer, the fast solution
switch system, the position sensor of the piezo actuator and the state of the multiple solution control
system are recorded for use in data analysis.
[(Fig._2)TD$FIG]
Fig. 2. Block diagram of apparatus control, data acquisition and analysis. Arrows show the signal/information ﬂow between
components.
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Data analysis software
Despite improvements in performance of spreadsheet and commercial statistical software in
recent years, they are usually not effective for processing large data sets. Data analysis software was
written in LabVIEW to visualize the acquired data, to process it, to ﬁtmodel curves to key components,
to visualize the results and to organize them for further analysis. The data analysis software (Fig. 4) is
loaded with saved experimental data. The tension traces are automatically identiﬁed, numbered and
activation and relaxation events are automatically and accurately selected. The valve conﬁguration
and thereforewhich activating solution is used for each contractile event is automatically determined.
The transition between the slow relaxation phase and the fast relaxation phase, and the segment of the
slow phase which is to be ﬁtted with a straight line is selected manually using cursors. After
calibration parameters are applied, the trace segment is ﬁtted with a single exponential. The ﬁtting
intervals can be easily adjusted with the cursors with constant visual feedback. The best-ﬁt
parameters are saved and transferred to another statistical program for further analysis.
Experimental evaluation
Fast two solution switching system
Rapid activation and relaxation in myoﬁbrils is achieved by switching the stream of experimental
solution directed at the mounted myoﬁbril. The solution streams were applied via the two adjacent
barrels of aQ pipette, whose position was controlled by a stepper motor. Single myoﬁbrils as well as
small bundles, due their small diameter (<3mm), equilibrate with the surrounding solution within
1ms, without being restricted by signiﬁcant diffusion time lag, so that the observed rates of force
development (kACT) and of relaxation (tLIN, kLIN, kREL) following quick increase and decrease in Ca
2+
level, respectively, correspond to the kinetics of the protein/protein and protein/ligand interactions
(Fig. 5).
[(Fig._3)TD$FIG]
Fig. 3. Software interface used for apparatus control. The graphs on the left are used to visualize acquired data from the
photodiode position sensor, the solution change system and length actuator. The graphs and panels on the right are used for the
construction of length change and solution-change protocols. It is possible to generate a sequence of control commands and
apply almost any combination of length and solution changes. The control protocol can be saved in a ﬁle to recall later. The
experimental record shown is that from a single human cardiac myoﬁbril subjected to length and solution changes that
simulate the heart cycle.
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kACT represents the cross-bridge turnover rate which is determined by the dynamic equilibrium
between the apparent rates with which cross bridges enter and leave the force generating states. kACT
can also affected on by the rate at which thin ﬁlaments are switched on by Ca2+. Isometric tension is
dependent on the number of attached myosins. Relaxation is initiated by Ca2+ dissociating from
troponin C coupled to the release of the C-terminus of troponin I from troponin C and its attachment to
actin, where it blocks cross-bridge binding cooperatively. The lag in the force trace has been ascribed
to the time taken for the occupancy of cycling cross-bridges to drop below the threshold for
cooperative activation of the thin ﬁlament, and the subsequent rapid-relaxation phase corresponds to
the detachment of the remaining cross-bridges, where reattachment is prevented in Ca2+-free
solution. These experimental parameters have been fully described by Stehle et al. [23].
[(Fig._5)TD$FIG]
Fig. 5. The time course of contraction and relaxation. (a) An example of a contraction-relaxation trace in a single mouse cardiac
myoﬁbril. Tension rises without a notable lag when [Ca2+] is increased. Tension development is ﬁtted with a single exponential
and the rate of contraction (kACT) and themaximum tension are calculated as the best-ﬁt parameters. (b) Relaxation following a
decrease in [Ca2+] is biphasic; the initial slow and nearly linear relaxation phase is followed by a fast phase which is well ﬁt by a
single exponential function. To characterize the overall myoﬁbril relaxation, the duration of the slow relaxation phase (tLIN), the
normalized slope (slope divided by Fmax value) of the best-ﬁt line and the rate of the fast relaxation phase (kREL) are calculated.
[(Fig._4)TD$FIG]
Fig. 4. The user interface of the data analysis program. This trace shows a Ca2+ curve experiment. The tension traces are
automatically identiﬁed, numbered and activation and relaxation events are automatically selected.
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Myoﬁbril length changes
An important feature of the experimental apparatus presented here is the ability to change
myoﬁbril length under computer control. A length transducer, composed of a microtool mounted
onto a piezo actuator is used to change themyoﬁbril length. This length actuatormakes it possible to
use a different approach to themeasurement of the rate of tension development. The application of a
quick decrease in myoﬁbril length (a quick release) applied during active contraction and
immediately followed by a restretch pulls off all actin-attachedmyosin heads. Immediately after the
restretch, the forcibly detached myosin heads reattach and force starts rising again [24] (Fig. 6a and
b). The use of myoﬁbrils, compared to the very much thicker muscle ﬁbers (20–150mm) avoids
delays in the rate of force development caused by diffusion of calcium into the ﬁber lattice which
might cause a lag in force development and affect the measurement of kACT. In the absence of a
diffusion induced lag in Ca2+-activation, kTR is equal to kACT (P=0.945, Fig. 6c). Comparison of kACT
with kTR shows that Ca
2+-switching is not rate-limiting factor for single myoﬁbrils. The time-course
of force development observed inmyoﬁbrils is therefore simpler than that observed in permeabilised
muscle ﬁbers [24].
Control of muscle and sarcomere length also enables us to study length-dependence of measured
parameters as well as viscous and elastic properties of myoﬁbrils. For instance, to measure passive
stiffness, myoﬁbrils in the relaxed state (in the absence of calcium) were stretched via the microtool
attached to the length actuator. The interval between stretch steps was 20s. The initial sarcomere
length was chosen such that the mounted myoﬁbril was not slack. Each myoﬁbril stretch caused an
increase in strain, followed by relaxationwhen the stretchingwas paused (Fig. 7a). The stretch and the
following release shows hysteresis (Fig. 7b) which is explained with the fact that the rate of domain
unfolding in the multi-domain protein titin, is slower than the refolding [25]. This explanation can be
tested by waiting a long time between releases on the return from the stretch.
Multi solution change system
This system enables us to determine dose-response relationships. For instance, the tension
response of myoﬁbrils to [Ca2+] is cooperative and well described by the Hill equation. The
relationship between contractility and Ca2+ concentration is examined by applying a range of
activating solutions of varying [Ca2+], and measuring the ensuing maximal isometric force (Fig. 8).
Apart from the maximal isometric force, the rates of activation and relaxation are measured over a
range of Ca2+ concentrations, providing more information about myoﬁbril kinetics as we have
[(Fig._6)TD$FIG]
Fig. 6. Release-restretch protocol applied tomouse cardiacmyoﬁbrils. (a) An example of the application of the release-restretch
procedure to a small myoﬁbril bundle. The restretch is applied 20ms after the end of the 20% length release. (b) The release-
restretch is shown on an expended time-scale with the length change protocol shown below. L/L0 is the ratio of the ongoing
myoﬁbril length to the initial length. (c) kTR is not signiﬁcantly different from kACT. kACT/kTR values (closed circles) were
calculated for 7 different myoﬁbrils. The mean and standard error is shown.
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demonstrated [9]. Furthermore, Ca2+ curves can be obtained at different initial sarcomere lengths to
enable us to measure length-dependent activation in single myoﬁbrils [9].
Cardiac cycle simulation
Combining precisely sequenced length and solution changes allows us to simulate complex
contraction patterns as observed during the in vivo heart cycle. The principal mechanical
characteristic of cardiac pumping is that contraction-relaxation cycles are coupled with heart
volume changes. According to this, the cardiac cycle of the left ventricle can be divided into 4 phases:
isovolumic contraction, ejection, isovolumic relaxation and ﬁlling. Cardiac contraction is not
isometric. During diastole the cardiac wall stretch, whereas during systole the muscles contract. The
changes in the left ventricle heart volume are coupled with the changes in myoﬁbril length. Thus,
based on the heart volume changes, the 4 phases of the typical human cardiac cycle are (for a heart rate
of 70beats/min): isovolumic contraction (70ms) and ejection (281ms), isovolumic relaxation (50ms),
and ventricular ﬁlling (461ms) [26,27]. Since, at the experimental temperature of 178C, the rate of
biological processes inmuscle is lower, and considering the temperature coefﬁcient Q102.6 [28], the
[(Fig._7)TD$FIG]
Fig. 7.Mechanical properties of human cardiac myoﬁbrils. (a) Passive tension changes (upper plot) in response to incremental
stretch and release (lower plot). (b) The relationship between sarcomere length and passive tension. The arrows show the
direction of the sarcomere length change.
[(Fig._8)TD$FIG]
Fig. 8. The Ca2+-sensitivity of tension in mouse myoﬁbrils. Representative Fmax – [Ca
2+] curve obtained from a small myoﬁbril
bundle of 2–8myoﬁbrils. The Hill equation was ﬁtted to the [Ca2+]-tension response and the best-ﬁt parameters – EC50, namely
the [Ca2+] for the development of halfmaximal force response, andHill slope (nH), themeasure of cooperativity, were calculated
for each myoﬁbril (n=8). Horizontal bars indicate the means with standard errors.
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time for contraction and ﬁlling was increased. The range of sarcomere lengths in the left ventricle
during a cardiac cycle varies between 1.8 and 2.3 in mammalian heart [29].
Using the computer-controlled piezo actuator we drove cyclical changes in myoﬁbril length,
similar to the changes in myoﬁbril length that occur during a cardiac cycle. The changes in myoﬁbril
length were synchronized with the changes in concentration of Ca2+ with a lag between activating
Ca2+ addition and shortening to allow for isometric (isovolumic) contraction (Fig. 9a and b). The area of
the loop (Fig. 9c) represents the amount of work done in each cycle and the reduction in tension at the
end of the ejection phase with shorter sarcomere length gives a homologue of end systolic pressure
volume relationship that indicates the length dependence of contractility.
Conclusions
The single myoﬁbril force assay system measures the physiological and mechanical parameters in
myoﬁbrils such as maximal force, Ca2+-sensitivity of tension, rates of contraction and relaxation and
myoﬁbril elasticity. By combining programmed length changes and solution changes the apparatus is
capable of making many more complex studies such as length-dependent modulation of
Ca2+-sensitivity or to mimic the cyclic changes in Ca2+ concentration and myoﬁbril length to
simulate the cardiac cycle.
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